Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ayman I Omar & Warren P Mason. (2009) Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas. Core Evidence 4, pages 93-111.
Read now
Read now
Articles from other publishers (20)
Deepak Babu, Ramulu Chintal, Manas Panigrahi & Prakash Babu Phanithi. (2022) Distinct expression and function of breast cancer metastasis suppressor 1 in mutant P53 glioblastoma. Cellular Oncology.
Crossref
Crossref
Andrew M. Hersh, George I. Jallo & Nir Shimony. (2022) Surgical approaches to intramedullary spinal cord astrocytomas in the age of genomics. Frontiers in Oncology 12.
Crossref
Crossref
Vaishali Suri, Swati Mahajan, Jyotsna Singh, Iman Dandapath, Rituparna Chakraborty, Afreen Khan, Mehar C. Sharma & Chitra Sarkar. 2022. The Biology of Glial Cells: Recent Advances. The Biology of Glial Cells: Recent Advances
353
386
.
Chih-Wei Chen, Cheng-Han Yang, Yuan-Ho Lin, Ya-Chin Hou, Tain-Junn Cheng, Sheng-Tsung Chang, Yu-Hua Huang, Shang-Ting Chung, Chung-Ching Chio, Yan-Shen Shan, Hung-Chi Cheng & Wen-Tsan Chang. (2021) The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway. International Journal of Molecular Sciences 22:7, pages 3782.
Crossref
Crossref
Dovilė Kavaliauskaitė, Donatas Stakišaitis, Justė Martinkutė, Lina Šlekienė, Arūnas Kazlauskas, Ingrida Balnytė, Vaiva Lesauskaitė & Angelija Valančiūtė. (2017) The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression. BioMed Research International 2017, pages 1-12.
Crossref
Crossref
Supriya Mallick, Rony Benson, Abdul Hakim & Goura K. Rath. (2016) Management of glioblastoma after recurrence: A changing paradigm. Journal of the Egyptian National Cancer Institute 28:4, pages 199-210.
Crossref
Crossref
Reza Akhavan-Sigari, Morteza Mazloum Farsi Baf, Vahid Ariabod, Veit Rohde & Saeed Rahighi. (2014)
Connection between Cell Phone use,
p53
Gene Expression in Different Zones of Glioblastoma Multiforme and Survival Prognoses
. Rare Tumors 6:3, pages 116-120.
Crossref
Crossref
Ayman I. Omar & Warren P. Mason. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II
451
466
.
Mariarita Santi & Elisabeth J. Rushing. 2012. Tumors of the Central Nervous System, Volume 6. Tumors of the Central Nervous System, Volume 6
35
41
.
Floris H. Groenendijk, Walter Taal, Hendrikus J. Dubbink, Cathleen R. Haarloo, Mathilde C. Kouwenhoven, Martin J. van den Bent, Johan M. Kros & Winand N. M. Dinjens. (2010) MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation. Journal of Neuro-Oncology 101:3, pages 405-417.
Crossref
Crossref
Georgia Levidou, Elias El-Habr, Angelica A. Saetta, Christine Bamias, Klea Katsougiannis, Efstratios Patsouris & Penelope Korkolopoulou. (2010) P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature. Journal of Neuro-Oncology 100:3, pages 363-371.
Crossref
Crossref
Robert Lober, Suash Sharma, Beverly Bell, Alan Free, Ramon Figueroa, Chris W Sheils, Mark Lee & John Cowell. (2017) Pediatric primary intramedullary spinal cord glioblastoma. Rare Tumors 2:3, pages 135-141.
Crossref
Crossref
Wei-Ying YueSu-Huan Yu, Shi-Guang Zhao & Zhong-Ping Chen. (2009) Molecular markers relating to malignant progression in Grade II astrocytoma. Journal of Neurosurgery 110:4, pages 709-714.
Crossref
Crossref
Chitra Sarkar, Asis Kumar Karak, Neera Nath, Mehar Chand Sharma, Ashok Kumar Mahapatra, Parthoprasad Chattopadhyay & Subrata Sinha. (2005) Apoptosis and proliferation: correlation with p53 in astrocytic tumours. Journal of Neuro-Oncology 73:2, pages 93-100.
Crossref
Crossref
Steven Brem, Susan Snodgrass, Margaret Booth-Jones, James Pearlman, Reed Murtagh, Frank Vrionis, S. Clifford Schold, Marguerite Wotoczek-Obadia & Amyn Rojiani. 2005. Textbook of Neuro-Oncology. Textbook of Neuro-Oncology
122
142
.
Bela Bodey, Stuart E. Siegel & Hans E. Kaiser. 2005. Molecular Markers of Brain Tumor Cells. Molecular Markers of Brain Tumor Cells
13
161
.
F S Pardo, D W Hsu, R Zeheb, J T Efird, P G Okunieff & D M Malkin. (2004) Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage. British Journal of Cancer 91:9, pages 1678-1686.
Crossref
Crossref
Chitra Sarkar, Subrata Sinha, Mehar Chand Sharma, Rajender Kumar & Veer Singh Mehta. (2004) Supratentorial glioblastoma in adults: Identification of subsets and their clinical correlation. Brain Tumor Pathology 21:1, pages 7-12.
Crossref
Crossref
Mariarita Santi, Hernando Mena, Kondi Wong, Kelly Koeller, Cara Olsen & Elisabeth J. Rushing. (2003) Spinal cord malignant astrocytomas. Cancer 98:3, pages 554-561.
Crossref
Crossref
Chitra Sarkar, Parthaprasad Chattopadhyay, Angela Mercy Ralte, Ashok K Mahapatra & Subrata Sinha. (2003) Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors. Cancer Genetics and Cytogenetics 144:2, pages 156-164.
Crossref
Crossref